| Ticker | RNA |
|---|---|
| ISIN | US04965N1046 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company's development stage product candidates include ATR 1072, a siRNA-based therapy targeting PRKAG2 for the treatment of PRKAG2 syndrome; and ATR 1086, a siRNA-based therapy targeting PLN for the treatment of PLN cardiomyopathy. It also focuses on pipeline to treat a range of genetic and cardiac di...
El precio actual de Avidity Biosciences, Inc. (RNA) es de 13,49 , con una variación del -2,60%.
Avidity Biosciences, Inc. opera en el sector Healthcare, industria Biotechnology.